Dr. David Medvedeff is the founder and CEO of Aspen RxHealth, a company disrupting the pharmacy profession by crowd sourcing passionate pharmacists to deliver patient care services on behalf of payers and providers. Prior to starting Aspen RxHealth, David served as president and CEO of several successful healthcare companies including Gold Standard (acquired by Reed Elsevier), Avatar International (acquired by Press Ganey Associates) and VUCA Health, where he currently serves as an Executive Chairperson. David’s professional accomplishments have been recognized with numerous industry accolades including the National Prescott Award for his exemplary leadership, the Next Generation Pharmacist Technology Innovator, and is the only two-time winner of the American Pharmacists Association Foundation’s Pinnacle Award.
David served on the Board of Directors of Strata Decision Technology (acquired by Roper Technologies) and Pharmacy Quality Solutions. Today he serves on the Executive Board of the Beryl Institute and is a Board Member and previous Chairperson of the Pharmacy Quality Alliance.
David studied organic chemistry at the University of Florida, where he earned his Doctor of Pharmacy and Master of Business Administration. He has served on the faculty of College of Pharmacy as an Associate Professor and has received the Outstanding Alumnus and the Outstanding Service Awards from the College.
